<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study no one of our 85 patients of Serbian origin with young-<z:hpo ids='HP_0003674'>onset</z:hpo> (&lt;/= 45 years) <z:chebi fb="0" ids="49168">dopa</z:chebi>-responsive <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 2 (SCA2) or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutation </plain></SENT>
<SENT sid="1" pm="."><plain>These data do not prove the significance of these two mutations in either <z:hpo ids='HP_0003745'>sporadic</z:hpo> or familial YOP suggestive of <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> </plain></SENT>
</text></document>